- Home
- BBIO vs WPP Comparison
BBIO vs WPP Comparison
Compare BBIO & WPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- WPP
- Stock Information
- Founded
- BBIO 2015
- WPP 1985
- Country
- BBIO United States
- WPP United Kingdom
- Employees
- BBIO N/A
- WPP N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- WPP Advertising
- Sector
- BBIO Health Care
- WPP Consumer Discretionary
- Exchange
- BBIO Nasdaq
- WPP Nasdaq
- Market Cap
- BBIO 8.0B
- WPP 7.7B
- IPO Year
- BBIO 2019
- WPP N/A
- Fundamental
- Price
- BBIO $42.78
- WPP $35.88
- Analyst Decision
- BBIO Strong Buy
- WPP Sell
- Analyst Count
- BBIO 14
- WPP 1
- Target Price
- BBIO $58.85
- WPP N/A
- AVG Volume (30 Days)
- BBIO 3.3M
- WPP 356.7K
- Earning Date
- BBIO 07-31-2025
- WPP 08-06-2025
- Dividend Yield
- BBIO N/A
- WPP 7.23%
- EPS Growth
- BBIO N/A
- WPP 389.11
- EPS
- BBIO N/A
- WPP 0.62
- Revenue
- BBIO $127,415,000.00
- WPP $18,454,623,978.00
- Revenue This Year
- BBIO $102.05
- WPP N/A
- Revenue Next Year
- BBIO $54.69
- WPP $1.46
- P/E Ratio
- BBIO N/A
- WPP $11.35
- Revenue Growth
- BBIO N/A
- WPP N/A
- 52 Week Low
- BBIO $21.72
- WPP $31.52
- 52 Week High
- BBIO $45.48
- WPP $57.37
- Technical
- Relative Strength Index (RSI)
- BBIO 62.54
- WPP 39.24
- Support Level
- BBIO $39.65
- WPP $34.90
- Resistance Level
- BBIO $45.48
- WPP $35.42
- Average True Range (ATR)
- BBIO 1.56
- WPP 0.53
- MACD
- BBIO 0.15
- WPP -0.08
- Stochastic Oscillator
- BBIO 60.90
- WPP 28.16
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About WPP WPP plc
Headquartered in the United Kingdom, WPP is one of the world's largest ad holding companies based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe.